Altria EPS Misses by $0.02 While 2026 Profit Outlook Tops Estimates After Price Hikes
Altria reported Q4 EPS of $1.30, missing the Zacks Consensus Estimate of $1.32 and slightly above last year’s $1.29. The company forecast full-year 2026 profit above analysts’ estimates, attributing the outlook to recent price increases on cigarettes and oral tobacco products.
1. Q4 Earnings Miss Estimates Despite Year-Over-Year Improvement
Altria reported adjusted earnings of $1.30 per share for the quarter ended December 31, 2025, falling short of the Zacks Consensus Estimate of $1.32. While this represents a 0.8% increase from the $1.29 recorded in Q4 2024, volume declines in combustible cigarettes and oral tobacco products weighed on profitability. The company’s operating income margin contracted by 120 basis points compared with the year-ago period, reflecting higher marketing spend and manufacturing costs. Investors had anticipated a flat to modest uptick in EPS, but Altria’s slight shortfall underscores pressure on core tobacco volumes.
2. 2026 Profit Outlook Raised on Price Hikes
Management guided full-year 2026 adjusted earnings above analysts’ consensus, driven by recent price increases across its Marlboro and oral tobacco portfolios. The company implemented average retail price hikes of 4% in Q4 2025 and plans an additional 3% increase in mid-2026. These actions are expected to offset ongoing volume headwinds, supporting a projected operating income growth of 3% to 5% year-over-year. Altria reiterated plans to leverage its manufacturing scale and disciplined cost management to sustain shareholder returns through dividend increases and opportunistic share repurchases.